Albemarle Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALB research report →
Range $109 – $224
Price Chart
About the company
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium.
- CEO
- Jerry Kent Jr.
- IPO
- 1994
- Employees
- 7,800
- HQ
- Charlotte, NC, US
AI snapshot
Six angles, distilled from the data.
ALB remains in a long downtrend after a major reset from its 52-week high of 219.70, with price still below the 200-day average near 146.5. The stock is trying to stabilize well above the 52-week low of 89.77, but the multi-month regime still favors a repair phase rather than a confirmed uptrend.
Street sentiment is constructive but cautious: consensus sits at Buy, with 21 buys, 20 holds, and 5 sells. The average target is 151.58, but recent cuts from Scotiabank, Citi, Truist, BofA, RBC, UBS, and others show expectations have been reset lower even as the rating mix stays supportive.
The earnings trend has been favorable, with ALB beating in 6 of the last 8 quarters and the latest print topping estimates by 0.8%. Next-year EPS estimates point sharply higher to 8.4606 from a 4.15 TTM base, so shareholders should watch whether lithium pricing and margin recovery keep translating into guidance support.
No notable discretionary insider buying or selling. Recent activity is dominated by awards and other automatic flows, with one CFO in-kind transaction and multiple director and officer grants, which read as compensation-related rather than a directional signal.
Profitability is solid but not yet elite: gross margin is 26.2%, operating margin 17.07%, and net margin 11.08%. Growth is mixed, with revenue up 18.8% year over year while earnings are still down 66.2%, reflecting a recovery that is improving but not fully normalized.
ALB stands out as a leveraged lithium and specialty-chemicals name, so its earnings swing more than diversified peers when pricing turns. Valuation is not cheap on a cyclically adjusted basis, but the current P/E of 15.64 is far below the stock’s prior peak multiple and leaves room if the recovery holds.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.41B
- P/E
- 19.68
- Fwd P/E
- 7.45
- PEG
- -0.00
- P/S
- 1.65
- P/B
- 0.96
- EV/EBITDA
- 7.41
- Div Yield
- 1.89%
- Gross Margin
- 25.92%
- Op Margin
- 14.35%
- Net Margin
- 11.08%
- ROE
- 6.78%
- ROIC
- 4.65%
Latest fiscal year · YoY change
- Revenue
- $5.14B-4.4%
- Gross Profit
- $671.62M+1014.9%
- Op Income
- $93.79M
- Net Income
- $-510,628,000+56.7%
- EPS
- $-5.75+48.7%
- OCF Growth
- +86.4%
- FCF Growth
- +169.8%
- 52W High
- $221.00
- 52W Low
- $79.38
- 50D MA
- $100.37
- 200D MA
- $144.01
- Beta
- 1.36
- RSI (14)
- 25
- Avg Volume
- 2.43M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Albemarle posted a strong Q3 with higher lithium pricing, specialty outperformance, and sharply improved cash generation, while raising its specialties outlook and cutting capex.· November 5, 2026
- Q3 net sales were $1.6 billion, up 19% year over year; adjusted EBITDA was $646 million, up 186%, and adjusted EBITDA margin expanded to 42%.
- Adjusted EPS was $2.58; reported net income was $297 million, or $2.15 per share.
- Specialties remains a standout: full-year adjusted EBITDA outlook was raised to $350 million-$375 million on strong year-to-date execution, steady demand, and cost/productivity actions.
- The company said it generated $1.5 billion of cash from operations and $1.2 billion of free cash flow year to date, with operating cash conversion at 67%.
- 2026 capex guidance was cut to $300 million-$350 million from approximately $500 million, while energy storage full-year volume guidance remained 225,000-235,000 tons LCE.
Albemarle reported third-quarter net sales of $1.6 billion, up 19% year over year, and adjusted EBITDA of $646 million, up 186% year over year. Adjusted EBITDA margin was 42%. Net income attributable to Albemarle was $297 million, or $2.15 per share, and adjusted EPS was $2.58 per share. By segment, energy storage adjusted EBITDA increased 351% on higher lithium pricing, while specialties adjusted EBITDA increased 31% on higher pricing and volumes. For the full year, specialties adjusted EBITDA outlook was increased to $350 million-$375 million. Energy storage full-year sales volumes were maintained at 225,000-235,000 tons LCE, and fourth-quarter energy storage net sales and adjusted EBITDA are expected to decline sequentially if lower market pricing persists. The company reduced 2026 capital expenditures to $300 million-$350 million from approximately $500 million, and said year-to-date operating cash flow was $1.5 billion with free cash flow of $1.2 billion.
Kent Masters described the quarter as another solid result driven by disciplined execution, higher lithium pricing, and outperformance in specialties. He emphasized that the company is benefiting from ongoing cost and productivity efforts, with more than $150 million in run-rate improvements year to date, and said the business is converting earnings into cash. His tone was constructive on end markets, resource development, and the company’s ability to grow through brownfield opportunities at Greenbushes, Wodgina, and the Salar de Atacama, while also highlighting a smooth CEO transition to Rag Udd in 2027.
Neal Sheorey focused on the financial upside from pricing, mix, and cost actions. He said Q3 net sales were $1.6 billion, adjusted EBITDA was $646 million, and margins expanded to 42%, while adjusted EPS was $2.58. He also highlighted $1.5 billion of cash from operations, $1.2 billion of free cash flow year to date, and 67% cash conversion, and explained that capex is being reduced to $300 million-$350 million through capital efficiency work and resequencing. He noted that sustaining capex is now expected to be less than $300 million in 2026 and that capex should rise only modestly in 2027.
Analysts focused on the drivers of specialty margin expansion, lithium price weakness in the spot market versus strong physical demand, the mix of contract versus spot volumes in energy storage, and what 2027 could look like for lithium demand, supply, and capex. Management said specialty improvement is a mix of pricing, volume, and cost productivity, while also noting $70 million-$90 million of unmitigated Middle East-related cost pressure that is being offset in part by the business. On lithium, they repeatedly said the physical market looks stronger than the traded market, inventories do not look excessive, and supply additions face uncertainty and economic hurdles. On 2027, they said energy storage volumes should grow to 240,000-260,000 tons LCE, capex should increase only modestly, and the company will provide more detail next quarter on contract mix and market assumptions.
The company is seeing strong demand in both EVs and stationary storage, and management believes lithium demand continues to outpace supply growth. Albemarle also has visible operational and resource catalysts, including CGP3 reaching 30 days of nameplate performance, higher production at Wodgina, and progress on the Salar de Atacama DLE project. Cost productivity and cash generation are improving, and the company sees room for further value creation through disciplined brownfield growth.
Management acknowledged sequentially lower energy storage sales and EBITDA expected in Q4 if lower lithium prices persist, plus margin pressure from higher-priced spodumene flowing through inventory. Specialty results still face $70 million-$90 million of unmitigated cost escalation tied to the Middle East conflict, even if partly offset. On lithium pricing, management repeatedly said the market is unusually volatile and disconnected from physical fundamentals, while 2027 supply remains uncertain because several projects may not come on as announced.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.7%
- Shares Outstanding
- 118.01M
- Float Shares
- 117.61M
of shares held by institutions
1,032 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ALB, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Sell | Oct 7, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 25, 26 | Filing → |
| John BoozmanSenate · AR | Buy | May 15, 26 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | May 12, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Buy | Apr 7, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Feb 12, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | Feb 24, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Oct 2, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Oct 31, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 14.53M | ▼ 74.50K |
| Blackrock, Inc. | 10.03M | ▲ 527.03K |
| Capital World Investors | 9.65M | ▼ 251.80K |
| Vanguard Capital Management LLC | 7.74M | ▲ 31.99K |
| Vanguard Portfolio Management LLC | 6.46M | ▲ 19.50K |
| State Street Corp | 6.32M | ▲ 823.26K |
| Fmr LLC | 4.61M | ▲ 1.92M |
| Franklin Templeton Inc | 3.38M | ▲ 2.90M |
| Geode Capital Management, LLC | 3.14M | ▲ 11.79K |
| Morgan Stanley | 3.05M | ▲ 154.59K |
| Primecap Management Co | 2.67M | ▲ 19.53K |
| Bank Of America Corp | 2.28M | ▼ 258.67K |
Held by 1,164 ETFs
Biggest fund positions in ALB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | Lima Cynthia Renee | other | 1,772 |
| Nov 6, 26 | Sheorey Neal Ravi | other | 849 |
| Oct 1, 26 | Wolff Alejandro Daniel | other | 45 |
| Sep 14, 26 | Norris Eric | other | 10,867 |
| Sep 14, 26 | Mummert Mark Richard | other | 6,086 |
| Sep 14, 26 | Gagarinas Autumn M. | other | 5,217 |
| Sep 1, 26 | Hood Max | other | 1,476 |
| Aug 24, 26 | Hood Max | other | 0 |
| Jul 21, 26 | DESALLES BARTOLOMEO EDUARDO | other | 1,375 |
| Jul 21, 26 | DESALLES BARTOLOMEO EDUARDO | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALB coverage
Recent articles, reports, and earnings notes.

Best Specialty Chemicals Stocks for November 2026: 7 Picks
Seven specialty chemicals stocks span fuel additives, life-science ingredients, activated carbon, petroleum additives, and electronics materials in a November 2026 countdown.

Super Startup, Revealed: Every Stock Adam O’Dell Is Teasing in Green Zone Fortunes
Adam O’Dell of Green Zone Fortunes and Money & Markets is pitching the “Super Startup” and Megablock Wealth Blueprint. We trace the Tesla-energy claims and identify the companies behind them.

America's New Power Grid, Revealed: Every Stock Adam O’Dell Is Teasing in Green Zone Fortunes
Adam O’Dell’s Green Zone Fortunes promotion, “America’s New Power Grid,” names three power plays. We trace the clues and test the claims.
Want a deeper read on ALB?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Is Albemarle (ALB) a Buy as Wall Street Analysts Look Optimistic?
zacks.com · Nov 11
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · Nov 10
Albemarle Corporation $ALB Shares Bought by AEGON ASSET MANAGEMENT UK Plc
defenseworld.net · Nov 10
6,425 Albemarle Corporation $ALB Shares Bought by CenterBook Partners LP
defenseworld.net · Nov 9
Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand
zacks.com · Nov 6
What Albemarle (ALB) Said on Its Q3 Earnings Call
marketbeat.com · Nov 6
Albemarle Corporation (ALB) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
ALB Q3 Earnings Beat Estimates on Higher Lithium Pricing
zacks.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice